איקסמפרה 15 מ"ג
Land: Israel
Språk: hebraisk
Kilde: Ministry of Health
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Aktiv ingrediens:
IXABEPILONE 15 MG
Tilgjengelig fra:
BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED
ATC-kode:
L01DC04
Legemiddelform:
POWDER FOR CONCENTRATE FOR INFUSION
Administreringsrute:
I.V
Produsert av:
CORDEN PHARMA LATINA S.P.A., ITALY
Terapeutisk gruppe:
IXABEPILONE
Indikasjoner:
Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.
Autorisasjon dato:
2012-01-01
